D. Galdermans

Broncholithiasis: present clinical spectrum.

J. V. van Meerbeeck, W. De Backer, P. Vermeire, 1990, Respiratory Medicine.

Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.

C. Dooms, K. Nackaerts, J. Vansteenkiste, 2003, Lung cancer.

Second primary lung cancer in Flanders: frequency, clinical presentation, treatment and prognosis.

M. Noppen, J. Tasson, G. Joos, 1996, Lung cancer.

A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.

G. Giaccone, R. V. van Klaveren, E. Smit, 2002, European journal of cancer.

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.

G. Giaccone, M. van Glabbeke, E. van Marck, 1996, British Journal of Cancer.

Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study).

J. V. van Meerbeeck, F. Bustin, L. de Vos, 2014, European journal of cancer care.

57 Gemcitabine (G) in malignant pleural mesothelioma (MPM): A phase II study

G. Giaccone, C. Gridelli, P. Baas, 1997 .